TW528606B - Pharmaceutical formulations for aerosols with two or more active substances - Google Patents

Pharmaceutical formulations for aerosols with two or more active substances Download PDF

Info

Publication number
TW528606B
TW528606B TW088110010A TW88110010A TW528606B TW 528606 B TW528606 B TW 528606B TW 088110010 A TW088110010 A TW 088110010A TW 88110010 A TW88110010 A TW 88110010A TW 528606 B TW528606 B TW 528606B
Authority
TW
Taiwan
Prior art keywords
patent application
scope
pharmaceutical preparation
item
stabilizer
Prior art date
Application number
TW088110010A
Other languages
English (en)
Chinese (zh)
Inventor
Daniel Patrick Mcnamara
George Anthony Destefano
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26046888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW528606(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE1998127178 external-priority patent/DE19827178A1/de
Priority claimed from DE1998142963 external-priority patent/DE19842963A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of TW528606B publication Critical patent/TW528606B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW088110010A 1998-06-18 1999-06-15 Pharmaceutical formulations for aerosols with two or more active substances TW528606B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1998127178 DE19827178A1 (de) 1998-06-18 1998-06-18 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen
DE1998142963 DE19842963A1 (de) 1998-09-19 1998-09-19 Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen

Publications (1)

Publication Number Publication Date
TW528606B true TW528606B (en) 2003-04-21

Family

ID=26046888

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088110010A TW528606B (en) 1998-06-18 1999-06-15 Pharmaceutical formulations for aerosols with two or more active substances

Country Status (33)

Country Link
EP (1) EP1087750B1 (sk)
JP (1) JP2003522102A (sk)
KR (1) KR100600423B1 (sk)
CN (1) CN1161104C (sk)
AR (1) AR019690A1 (sk)
AT (1) ATE253896T1 (sk)
AU (1) AU759222B2 (sk)
BG (1) BG65252B1 (sk)
BR (1) BR9911351A (sk)
CA (1) CA2335065C (sk)
CO (1) CO5070580A1 (sk)
CZ (1) CZ300910B6 (sk)
DE (1) DE69912781T2 (sk)
DK (1) DK1087750T3 (sk)
EE (1) EE04450B1 (sk)
ES (1) ES2211108T3 (sk)
HK (1) HK1037974A1 (sk)
HR (1) HRP20000867B1 (sk)
HU (1) HU229064B1 (sk)
ID (1) ID27554A (sk)
IL (2) IL140353A0 (sk)
ME (1) ME00838B (sk)
MY (1) MY121073A (sk)
NO (1) NO329416B1 (sk)
NZ (1) NZ509418A (sk)
PL (1) PL193695B1 (sk)
PT (1) PT1087750E (sk)
RS (1) RS49977B (sk)
RU (1) RU2218152C2 (sk)
SK (1) SK284756B6 (sk)
TR (1) TR200003721T2 (sk)
TW (1) TW528606B (sk)
WO (1) WO1999065464A1 (sk)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
EP1248597B1 (en) * 1999-12-24 2005-03-30 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008485D0 (en) * 2000-04-07 2000-05-24 Glaxo Group Ltd Pharmaceutical compositions
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
PL208686B1 (pl) 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
JP2010184937A (ja) * 2001-10-26 2010-08-26 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、キット、吸入溶液を中に有する１容器を作成する方法、および、吸入溶液を作成する方法
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN101175479A (zh) * 2005-03-16 2008-05-07 霍尼韦尔国际公司 药物递送制剂、装置和方法
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US8061350B2 (en) 2006-06-02 2011-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process and device for dosing pharmaceutical agents
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
ES2298049B1 (es) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US9119924B2 (en) 2009-03-17 2015-09-01 Boehringer Ingelheim International Gmbh Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
AU2010323220B2 (en) 2009-11-25 2015-04-23 Boehringer Ingelheim International Gmbh Nebulizer
US20120272951A1 (en) 2009-12-16 2012-11-01 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
PL2835146T3 (pl) 2013-08-09 2021-04-06 Boehringer Ingelheim International Gmbh Nebulizator
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
KR102443737B1 (ko) 2014-05-07 2022-09-19 베링거 인겔하임 인터내셔날 게엠베하 컨테이너, 분무기 및 사용 방법
JP6559157B2 (ja) 2014-05-07 2019-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
PL3139981T3 (pl) 2014-05-07 2021-06-14 Boehringer Ingelheim International Gmbh Nebulizator
WO2020152548A1 (en) * 2019-01-24 2020-07-30 Glenmark Pharmaceuticals Limited Stable aerosol inhalation compositions of formoterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
WO1994013263A1 (en) * 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
US5603918A (en) * 1995-06-09 1997-02-18 Boehringer Ingelheim Pharmaceuticals, Inc. Aerosol composition of a salt of ipratropium and a salt of albuterol
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation

Also Published As

Publication number Publication date
PL193695B1 (pl) 2007-03-30
YU80000A (sh) 2003-04-30
EP1087750B1 (en) 2003-11-12
KR100600423B1 (ko) 2006-07-13
CN1307470A (zh) 2001-08-08
WO1999065464A1 (en) 1999-12-23
DE69912781D1 (de) 2003-12-18
ES2211108T3 (es) 2004-07-01
NZ509418A (en) 2003-06-30
AR019690A1 (es) 2002-03-13
CA2335065C (en) 2008-06-03
IL140353A0 (en) 2002-02-10
TR200003721T2 (tr) 2001-06-21
ID27554A (id) 2001-04-12
DE69912781T2 (de) 2004-10-21
RU2218152C2 (ru) 2003-12-10
EP1087750A1 (en) 2001-04-04
CN1161104C (zh) 2004-08-11
BG105033A (en) 2001-09-28
NO20006318L (no) 2001-01-30
DK1087750T3 (da) 2004-01-26
NO20006318D0 (no) 2000-12-12
HUP0104734A3 (en) 2003-05-28
MY121073A (en) 2005-12-30
HK1037974A1 (en) 2002-03-01
RS49977B (sr) 2008-09-29
BG65252B1 (bg) 2007-10-31
EE04450B1 (et) 2005-04-15
HU229064B1 (en) 2013-07-29
BR9911351A (pt) 2001-03-13
CZ20004750A3 (en) 2001-05-16
NO329416B1 (no) 2010-10-18
IL140353A (en) 2006-09-05
ME00838B (me) 2008-09-29
PL345685A1 (en) 2002-01-02
SK19392000A3 (sk) 2001-07-10
JP2003522102A (ja) 2003-07-22
CA2335065A1 (en) 1999-12-23
EE200000759A (et) 2002-04-15
HRP20000867A2 (en) 2001-10-31
KR20010072621A (ko) 2001-07-31
HUP0104734A2 (hu) 2002-05-29
ATE253896T1 (de) 2003-11-15
CZ300910B6 (cs) 2009-09-09
AU4552199A (en) 2000-01-05
AU759222B2 (en) 2003-04-10
PT1087750E (pt) 2004-02-27
SK284756B6 (sk) 2005-11-03
CO5070580A1 (es) 2001-08-28
HRP20000867B1 (en) 2010-10-31

Similar Documents

Publication Publication Date Title
TW528606B (en) Pharmaceutical formulations for aerosols with two or more active substances
US6423298B2 (en) Pharmaceutical formulations for aerosols with two or more active substances
JP3056784B2 (ja) エアゾール医薬製剤
JP2786493B2 (ja) 医薬エアゾール製剤
EP1066828B9 (en) Aerosol compositions
JP5392880B2 (ja) 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP3776124B2 (ja) 少なくとも一種の糖を含んでなる医薬用エアゾール
JP4380802B2 (ja) 医薬用エアロゾル組成物
JP4921639B2 (ja) フルオロアルカン、ブデソニド及びホルモテロールを含有する医薬用エアゾール製剤
US20030190287A1 (en) Pharaceutical aerosol composition
BRPI0711688A2 (pt) formulação farmacêutica, método para preparar uma formulação farmacêutica, inalador de dose controlada, método para tratar broncoconstrição, broncoespasmos, asma e distúrbiis relacionados e uso de uma formulação
PL196269B1 (pl) Preparat aerozolowy roztworu, dostosowany do zastosowania w ciśnieniowym pojemniku aerozolowym, zawierający budesonid, wodorofluoroalkan i współrozpuszczalnik
JP5938476B2 (ja) 呼吸器疾患を治療するための定量噴霧式吸入剤を調製する方法
AU774250B2 (en) Pharmaceutical aerosol composition
RU2098082C1 (ru) Аэрозольная лекарственная композиция для ингаляций (варианты)
UA73721C2 (en) Pharmaceutical formulations for aerosols with at least two or more active substances
MXPA01006082A (en) Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MK4A Expiration of patent term of an invention patent